GPP
OYST

Great Point Partners’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Great Point Partners’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-70,121
Closed -$1.48M – 45
2020
Q3 		$1.48M Sell
70,121
-144,510
-67% -$3.38M 0.13% 34
2020
Q2 		$6.2M Buy
+214,631
New +$6.47M 0.5% 31

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Great Point Partners's OYST Position: Q4 2020 in Review

Great Point Partners sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2020, closing a stake of 70,121 shares — an estimated $1.48M sold.

Great Point Partners first reported a position in OYST in Q2 2020 and held it in 2 quarters. The position peaked at $6.2M in Q2 2020. 60 funds tracked by Wall St. Rank hold OYST as of Q4 2020.

  • Great Point Partners reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Great Point Partners sold 70,121 Oyster Point Pharma, Inc. Common Stock shares in Q4 2020, an estimated $1.48M.
  • Great Point Partners first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Great Point Partners's Oyster Point Pharma, Inc. Common Stock position peaked at $6.2M in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2020.

Based on Great Point Partners's 13F filing for Q4 2020, filed 16 Feb 2021.